Atrial Fibrillation Ablation in Patients With Chronic Kidney Disease: A Review of Literature

被引：1

作者：

Basnet, Arjun ^{[1
]}

Naeem, Azka ^{[1
]}

Sharma, Nava R. ^{[2
]}

Lamichhane, Saral ^{[3
]}

Kansakar, Sajog ^{[4
]}

Gautam, Sudarshan ^{[1
]}

Tiwari, Kripa ^{[1
]}

Seitillari, Armando ^{[1
]}

Thomas, Remil ^{[5
]}

Janga, Kalyana ^{[6
]}

机构：

[1] Miamonides Med Ctr, Internal Med, Brooklyn, NY USA

[2] Manipal Coll Med Sci, Med, Pokhara, Nepal

[3] Gandaki Med Coll, Internal Med, Pokhara, Nepal

[4] Manipal Coll Med Sci, Internal Med, Pokhara, Nepal

[5] Nuvance Hlth Vassar Bros Med Ctr, Internal Med, New York, NY USA

[6] Maimonides Hosp, Nephrol, Brooklyn, NY USA

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 10期

关键词：

atrial fibrillation ablation; atrial fib ablation; radio-frequency ablation; atrial fibrillation recurrence; chronic kidney disease (ckd); CATHETER ABLATION; PULMONARY VEIN; RADIOFREQUENCY ABLATION; RISK; CRYOBALLOON; RECURRENCE; PERSISTENT; OUTCOMES; PREVALENCE; THERAPY;

D O I：

10.7759/cureus.46545

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation (AF) is a common arrhythmia among patients with chronic kidney disease (CKD), which leads to increased cardiovascular complications. Catheter ablation (CA) has emerged as an effective and safe treatment for AF in CKD patients. CA offers tailored treatment strategies and presents a safer alternative with fewer adverse outcomes than anti-arrhythmic agents. Although CKD patients undergoing ablation have similar complication rates to non-CKD patients, they face a higher risk of hospitalization due to heart failure. Furthermore, CA shows promise in improving kidney function, particularly in individuals who maintain sinus rhythm. Future research should address limitations by including advanced CKD patients, conducting longer-term follow-ups, and developing individualized treatment approaches.

引用

页数：7

共 47 条

[1] Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring A Randomized Clinical Trial
Andrade, Jason G.
Champagne, Jean
Dubuc, Marc
Deyell, Marc W.
Verma, Atul
Macle, Laurent
Leong-Sit, Peter
Novak, Paul
Badra-Verdu, Mariano
Sapp, John
Mangat, Iqwal
Khoo, Clarence
Steinberg, Christian
Bennett, Matthew T.
Tang, Anthony S. L.
Khairy, Paul
Parkash, Ratika
Guerra, Peter
Dyrda, Katia
Rivard, Lena
Racine, Normand
Sterns, Lawrence
Leather, Rick
Seifer, Colette
Jolly, Umjeet
Raymond, Jean-Marc
Roux, Jean-Francois
Nault, Isabelle
Sarrazin, Jean-Francois
Ramanathan, Krishnan
Cheung, Christopher
Fordyce, Christopher
McKinney, Jimmy
Luong, Christina
Rizkallah, Jacques
Angaran, Paul
Ha, Andrew
Glover, Benedict
Skanes, Allan
Gula, Lorne
[J]. CIRCULATION, 2019, 140 (22) : 1779 - 1788
[2] Management of Adults with Newly Diagnosed Atrial Fibrillation with and without CKD
Bansal, Nisha
Zelnick, Leila R.
Reynolds, Kristi
Harrison, Teresa N.
Lee, Ming-Sum
Singer, Daniel E.
Sung, Sue Hee
Fan, Dongjie
Go, Alan S.
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (02): : 442 - 453
[3] Atrial Fibrillation and Risk of ESRD in Adults with CKD
Bansal, Nisha
Xie, Dawei
Tao, Kelvin
Chen, Jing
Deo, Rajat
Horwitz, Edward
Hsu, Chi-yuan
Kallem, Radha Krishna
Keane, Martin G.
Lora, Claudia M.
Raj, Dominic
Soliman, Elsayed Z.
Strauss, Louise
Wolf, Myles
Go, Alan S.
[J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (07): : 1189 - 1196
[4] Incident Atrial Fibrillation and Risk of End-Stage Renal Disease in Adults With Chronic Kidney Disease
Bansal, Nisha
Fan, Dongjie
Hsu, Chi-yuan
Ordonez, Juan D.
Marcus, Greg M.
Go, Alan S.
[J]. CIRCULATION, 2013, 127 (05) : 569 - 574
[5] A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease
Bianchi, S
Bigazzi, R
Caiazza, A
Campese, VM
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (03) : 565 - 570
[6] Outcomes of long-standing persistent atrial fibrillation ablation: A systematic review
Brooks, Anthony G.
Stiles, Martin K.
Laborderie, Julien
Lau, Dennis H.
Kuklik, Pawel
Shipp, Nicholas J.
Hsu, Li-Fern
Sanders, Prashanthan
[J]. HEART RHYTHM, 2010, 7 (06) : 835 - 846
[7] Calkins H, 2018, EUROPACE, V20, P157, DOI [10.1093/europace/eux275, 10.1093/europace/eux274, 10.1016/j.hrthm.2017.05.012]
[8] Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease The Stockholm CREAtinine Measurements (SCREAM) Project
Carrero, Juan Jesus
Trevisan, Marco
Sood, Manish M.
Barany, Peter
Xu, Hong
Evans, Marie
Friberg, Leif
Szummer, Karolina
[J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (09): : 1314 - 1320
[9] Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study
Ceynowa-Sielawko, Beata
Wybraniec, Maciej T.
Topp-Zielinska, Aleksandra
Maciag, Aleksander
Miskowiec, Dawid
Balsam, Pawel
Wojcik, Maciej
Wrobel, Wojciech
Farkowski, Michal M.
Cwiek-Rebowska, Edyta
Ozieranski, Krzysztof
Blaszczyk, Robert
Bula, Karolina
Dembowski, Tomasz
Peller, Michal
Krzowski, Bartosz
Wanha, Wojciech
Kozinski, Marek
Kasprzak, Jaroslaw D.
Szwed, Hanna
Mizia-Stec, Katarzyna
Szolkiewicz, Marek
[J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (08)
[10] The Uremic Toxin Indoxyl Sulfate Increases Pulmonary Vein and Atrial Arrhythmogenesis
Chen, Wei-Ta
Chen, Yao-Chang
Hsieh, Ming-Hsiung
Huang, Shih-Yu
Kao, Yu-Hsun
Chen, Yi-Ann
Lin, Yung-Kuo
Chen, Shih-Ann
Chen, Yi-Jen
[J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2015, 26 (02) : 203 - 210

← 1 2 3 4 5 →